Key result
Adipose tissue macrophages play a key role in triggering inflammation and driving the progression of nonalcoholic fatty liver disease to nonalcoholic steatohepatitis.
Why the study?
Identifying pathogenic factors triggering inflammation and driving the transition from nonalcoholic fatty liver to NASH is a key need, particularly regarding the role of adipose tissue events.
This review highlights the role of adipose tissue macrophages and their metabolic profiles in triggering inflammation and driving the progression of nonalcoholic fatty liver disease to steatohepatitis.
Encourages macrophage-targeted therapies in NASH; leaves open clinical efficacy pending interventional trials.
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western countries that could lead to serious health problems including liver failure, cancer, or death. The term NAFLD includes a spectrum of disease states with histological features ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). A key aspect within this research field is the identification of pathogenic factors that trigger inflammation, thus fueling the transition from nonalcoholic fatty liver to NASH. These inflammatory triggers may originate from within the liver as a result of innate immune cell activation and/or hepatocyte injury. Additionally, they may originate from other sites such as adipose tissue or the intestinal tract. In the current review, the authors will primarily focus on events within adipose tissue which may be of importance in triggering the disease progression. They specifically focus on the role of adipose tissue macrophages during NAFLD pathogenesis and how microenvironmental factors may shape their metabolic profile. They further dissect how redirecting the macrophage's metabolic profile alters their immunological functions. Finally, they discuss the opportunities and challenges of targeting macrophages to interfere in disease progression.
No takes yet. Share an insight, caveat, or question.
Korf et al. (2019) conducted a review in Nonalcoholic fatty liver disease (NAFLD). Adipose tissue macrophages play a key role in triggering inflammation and driving the progression of nonalcoholic fatty liver disease to nonalcoholic steatohepatitis.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: